Influenza immunization in egg allergy: An update for the 2011-2012 season

Clinical and Experimental Allergy

Volumn 41, Issue 10, 2011, Pages 1367-1370

  Erlewyn Lajeunesse, M ^a,b   Lucas, J S A ^a,b   Warner, J O ^c  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EGG PROTEIN; ENZIRA; IMUVAC; INFLUENZA VACCINE; OVALBUMIN; PREFLUCEL; UNCLASSIFIED DRUG; VIROFLU;

2009 H1N1 INFLUENZA; ARTICLE; CELL CULTURE; DRUG EFFICACY; DRUG SAFETY; EGG ALLERGY; HIGH RISK PATIENT; HUMAN; INFLUENZA VACCINATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEASONAL INFLUENZA; SINGLE DRUG DOSE; TREATMENT CONTRAINDICATION; VIRUS VIRULENCE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EGG HYPERSENSITIVITY; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS VACCINATION; MIDDLE AGED; OVALBUMIN; PRACTICE GUIDELINES AS TOPIC; SEASONS; YOUNG ADULT;

EID: 80052972269     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03842.x     Document Type: Article

References (14)

1. Erlewyn-Lajeunesse M, Brathwaite N, Lucas JS et al. Recommendations for the administration of influenza vaccine in children allergic to egg. BMJ 2009; 339:b3680.
2. Department of Health. Seasonal winter flu plan 2011/12. 25-5-2011 Gateway reference 16004. Available at (accessed 22 June 2011).
3. Gagnon R, Primeau MN, Des Roches A et al. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. J Allergy Clin Immunol 2010; 126:317-23.
4. Chung EY, Huang L, Schneider L. Safety of influenza vaccine administration in egg-allergic patients. Pediatrics 2010; 125:e1024-30.
5. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2008; 63(Suppl. 4):1-121.
6. Mark C. Large variations in the ovalbumin content in six European influenza vaccines. Pharmeur Sci Notes 2006; 2006:27-9.
7. Li JT, Rank MA, Squillace DL et al. Ovalbumin content of influenza vaccines. J Allergy Clin Immunol 2010; 125:1412-3.
8. Zeiger RS. Current issues with influenza vaccination in egg allergy. J Allergy Clin Immunol 2002; 110:834-40.
9. Waddington CS, Walker WT, Oeser C et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 2010; 340:c2649.
10. European Pharmacopoea. Influenza vaccine (split virion, inactivated). 2005 01/2005:0158. Available at (accessed 22 June 2011).
11. James JM, Zeiger RS, Lester MR et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 1998; 133:624-8.
12. Esposito S, Gasparini C, Martelli A et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine 2008; 26:4664-8.
13. Salisbury D. Immunisation against infectious disease. 4th Edn. London: TSO, 2006.
14. Nasser S, Brathwaite N. Swine flu vaccination in patients with egg allergy. Clin Exp Allergy 2009; 39:1288-90.